Cargando…

Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era

Adrenocortical carcinoma (ACC) is a rare and often fatal cancer, affecting ~1 person per million per year worldwide. Approximately 75% of patients with ACC eventually develop metastases and progress on the few available standard-of-care medical therapies, highlighting an incredible need for an impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Dipika R, Lerario, Antonio Marcondes, Hammer, Gary D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215083/ https://www.ncbi.nlm.nih.gov/pubmed/30402590 http://dx.doi.org/10.1210/js.2018-00197

Ejemplares similares

PSUN13 Transcriptional and epigenetic landscapes of adrenocortical tumors
por: Lerario, Antonio, et al.
Publicado: (2022)

SUN-LB39 ATAC-Seq Reveals Dynamic Changes in Chromatin Accessibility Following PKA Activation in NCI-H295R Adrenocortical Cells
por: LaPensee, Christopher Ryan, et al.
Publicado: (2020)

FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
por: Tamburello, Mariangela, et al.
Publicado: (2022)

FRI192 Serum Steroid Biomarkers For The Differential Diagnosis Of Adrenocortical Carcinoma (ACC) And Adrenocortical Adenoma (ACA)
por: van Rooyen, Desmaré, et al.
Publicado: (2023)

Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma
por: Lerario, Antonio M., et al.
Publicado: (2018)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
por: Penny, Morgan K., et al.
Publicado: (2023)

OR29-3 Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma
por: Mohan, Dipika, et al.
Publicado: (2019)

An update on adrenocortical cell lines of human origin
por: Sigala, Sandra, et al.
Publicado: (2022)

Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
por: Turla, Antonella, et al.
Publicado: (2022)

SAT-LB34 Repressive Epigenetic Programs Reinforce Steroidogenic Differentiation and Wnt/β-Catenin Signaling in Aggressive Adrenocortical Carcinoma
por: Mohan, Dipika R, et al.
Publicado: (2020)

Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents
por: Al-Fakhrany, Omnia Momtaz, et al.
Publicado: (2023)

RF21 | PSAT76 Epigenetic Programs Stabilize a Differentiated Cell State Required for Sustained Proliferation in Adrenocortical Carcinoma
por: Mohan, Dipika, et al.
Publicado: (2022)

The challenge of developmental therapeutics for adrenocortical carcinoma
por: Costa, Ricardo, et al.
Publicado: (2016)

Analyzing the genomic variation of microbial cell factories in the era of “New Biotechnology”
por: Herrgård, Markus, et al.
Publicado: (2012)

Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
por: Roszczenko-Jasińska, Paula, et al.
Publicado: (2020)

Genome editing of therapeutic T cells
por: Qasim, Waseem
Publicado: (2021)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

New Approaches to Comparative and Animal Stress Biology Research in the Post-genomic Era: A Contextual Overview
por: Biggar, Kyle K., et al.
Publicado: (2014)

Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets?
por: Corona, Juan Carlos, et al.
Publicado: (2014)

Therapeutic targeting of cellular stress responses in cancer
por: Chen, Miao, et al.
Publicado: (2018)

Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex
por: Lerario, Antonio Marcondes, et al.
Publicado: (2017)

A potential therapeutic strategy for prostatic disease by targeting the oral microbiome
por: Fang, Cheng, et al.
Publicado: (2020)

Editorial focus: entering into the non-coding RNA era
por: Bartoszewski, Rafal, et al.
Publicado: (2018)

X-Linked Hypophosphatemia: A New Era in Management
por: Dahir, Kathryn, et al.
Publicado: (2020)

Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
por: Addison, Daniel, et al.
Publicado: (2020)

G protein-coupled receptors as new therapeutic targets for type 2 diabetes
por: Reimann, Frank, et al.
Publicado: (2015)

RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
por: Wang, Shuai, et al.
Publicado: (2020)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020)

Transcription factor Nrf2 as a potential therapeutic target for COVID-19
por: Wang, Yifan, et al.
Publicado: (2022)

Genetics of Primary Ovarian Insufficiency in the Next-Generation Sequencing Era
por: França, Monica Malheiros, et al.
Publicado: (2019)

Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
por: Shankar, Akshay, et al.
Publicado: (2022)

Apoptosis regulation in adrenocortical carcinoma
por: Pereira, Sofia S, et al.
Publicado: (2019)

Modulation of L-type calcium channels in Alzheimer’s disease: A potential therapeutic target
por: Crossley, Chelsea A., et al.
Publicado: (2022)

POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells
por: França, Monica Malheiros, et al.
Publicado: (2015)

Radiation meets immunotherapy – a perfect match in the era of combination therapy?
por: Soukup, Klara, et al.
Publicado: (2015)

Population-scale genotyping of structural variation in the era of long-read sequencing
por: Quan, Cheng, et al.
Publicado: (2022)

Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment
por: Miquelotti, Luísa Biscaglia, et al.
Publicado: (2023)

Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer’s disease and other proteinopathies
por: Mohaupt, Pablo, et al.
Publicado: (2023)

Medical Approaches in Adrenocortical Carcinoma
por: Paragliola, Rosa Maria, et al.
Publicado: (2020)

KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
por: Zhou, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ghq6ev95f4l4uivrru4t608flu